> Hence selection pressures will skew it towards “Antibody resistant, lower fatality” Those selection pressures don't appear until the exponential growth slows

> Hence selection pressures will skew it towards “Antibody resistant, lower fatality” Those selection pressures don't appear until the exponential growth slows down. From the virus perspective right now and in the near term it's super successful, so there's no need to adapt.